دورية أكاديمية

Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome

التفاصيل البيبلوغرافية
العنوان: Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome
المؤلفون: Liwen Chen, Zhujun Cao, Lei Yan, Yezhou Ding, Xinghua Shen, Kehui Liu, Xiaogang Xiang, Qing Xie, Chuanwu Zhu, Shisan Bao, Hui Wang
المصدر: Frontiers in Physiology, Vol 11 (2020)
بيانات النشر: Frontiers Media S.A., 2020.
سنة النشر: 2020
المجموعة: LCC:Physiology
مصطلحات موضوعية: HBV, acute-on-chronic liver failure, cell death, RIPK3, necroptosis, Physiology, QP1-981
الوصف: Background and AimsNecroptosis is a newly identified type of cell death with programmed pathways. The current study was performed to investigate necroptosis by measuring its key regulators; receptor interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) in patients with Hepatitis B virus (HBV) related acute-on-chronic liver failure (ACLF).MethodsHBV-related ACLF (HBV-ACLF) patients (n = 90), non-ACLF patients without cirrhosis (N = 70), patients with cirrhosis (N = 40), and healthy controls (HCs; n = 70) were enrolled in the study. All patients were subject to serum RIPK3 measurement. Hepatic RIPK3 and MLKL were also determined in the livers of 18 patients and five donors, using immunohistochemistry.ResultsSerum RIPK3 was significantly elevated in HBV-ACLF patients compared to that of non-ACLF patients and the HCs. Serum RIPK3 in ACLF patients at recruitment was significantly higher in non-survivors than those in survivors at the 90-day follow-up. The predictive accuracy of serum RIPK3 at the 90-day outcome was relatively good with an area under the receiver operating curve (AUROC) of 0.72 (p < 0.001), similar to that of the model of end-staged liver disease (MELD) score (0.76, p < 0.001). The combined use of RIPK3 and MELD score further increased the AUROC to 0.80. The hepatic RIPK3 and MLKL measured by immunohistochemistry, significantly increased in the patients with HBV-ACLF than in the patients without ACLF and the HCs.ConclusionCirculating RIPK3 was significantly increased in patients with HBV-ACLF and was associated with a clinical outcome. The improved combined objective scores could offer additional prognostic value in ACLF patients, for physicians with more accurate expectations.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1664-042X
العلاقة: https://www.frontiersin.org/article/10.3389/fphys.2020.00526/fullTest; https://doaj.org/toc/1664-042XTest
DOI: 10.3389/fphys.2020.00526
الوصول الحر: https://doaj.org/article/cd6dc1ef369b4a939231d82d3be3ec1dTest
رقم الانضمام: edsdoj.6dc1ef369b4a939231d82d3be3ec1d
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1664042X
DOI:10.3389/fphys.2020.00526